Pfizer still holds the lead in the erectile dysfunction market even as Viagra sales falter

Indonesia Berita Berita

Pfizer still holds the lead in the erectile dysfunction market even as Viagra sales falter
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 CNBC
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 72%

Despite competition from other drugmakers, Pfizer has been able to maintain a significant share in the erectile dysfunction market thanks in part to launching its own generic version of the blue, diamond-shaped pill.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

CNBC /  🏆 12. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Pfizer Japan recalls high blood pressure drug over cancer-causing impurityPfizer Japan recalls high blood pressure drug over cancer-causing impurityThe Japanese subsidiary of Pfizer Inc is recalling a drug for high blood pressur...
Baca lebih lajut »

Merck, Pfizer combo treatment boosts kidney cancer survivalMerck, Pfizer combo treatment boosts kidney cancer survivalDrugmaker Merck & Co Inc said on Monday that the combination of its cancer immun...
Baca lebih lajut »

Stocks making the biggest moves midday: Avis Budget Group, Pfizer, Tesla & moreStocks making the biggest moves midday: Avis Budget Group, Pfizer, Tesla & moreThese are the stocks posting the largest moves midday.
Baca lebih lajut »

A buzzy startup is shaking up men's health by prescribing generic Viagra online. But a move to relax guidelines has raised concerns among some of its doctor partners.A buzzy startup is shaking up men's health by prescribing generic Viagra online. But a move to relax guidelines has raised concerns among some of its doctor partners.A secret group chat reveals doctors' concerns about guidelines for treating erectile dysfunction at Hims, which is nearing a $1 billion valuation.
Baca lebih lajut »

Trendy startup Hims wants to shake up men's health by prescribing generic Viagra online and is nearing a $1 billion valuation. But a move to relax guidelines has raised concerns among some of its doctor partners.Trendy startup Hims wants to shake up men's health by prescribing generic Viagra online and is nearing a $1 billion valuation. But a move to relax guidelines has raised concerns among some of its doctor partners.A secret group chat revealed doctors' concerns about guidelines for treating erectile dysfunction at Hims.
Baca lebih lajut »

One of the world's largest crypto exchanges says it's still profitable 'even in this bear market'One of the world's largest crypto exchanges says it's still profitable 'even in this bear market''To date, even in this bear market, we still run a profitable business,' Binance CFO Wei Zhou told CNBC.
Baca lebih lajut »

BP CEO Bob Dudley warns oil market uncertainty could lead to a 'real crunch'BP CEO Bob Dudley warns oil market uncertainty could lead to a 'real crunch'A flurry of intensifying risks could trigger an energy market 'crunch' over the coming months, according to the chief executive of BP.
Baca lebih lajut »

After going up for six straight weeks, the stock market comeback is on hold – here's whyAfter going up for six straight weeks, the stock market comeback is on hold – here's whyThe Dow Jones Industrial Average is headed for its first negative week of 2019 and there a few key reasons why the stock market's recent rally has slowed.
Baca lebih lajut »

Pfizer Japan recalls high blood pressure drug over cancer-causing impurityPfizer Japan recalls high blood pressure drug over cancer-causing impurityThe Japanese subsidiary of Pfizer Inc is recalling a drug for high blood pressur...
Baca lebih lajut »



Render Time: 2025-03-13 03:57:31